Metabolic markers during pregnancy and their association with maternal and newborn weight status.
Obesity during pregnancy increases the risk of adverse clinical outcomes and is associated with low-grade chronic inflammation. We describe maternal metabolic risk and inflammation by maternal weight status, and evaluate the association of metabolic and inflammatory markers with birthweight in a gro...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5531808?pdf=render |
id |
doaj-fb0b5c8138b8461db59db8f514f0541f |
---|---|
record_format |
Article |
spelling |
doaj-fb0b5c8138b8461db59db8f514f0541f2020-11-24T22:17:19ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01127e018087410.1371/journal.pone.0180874Metabolic markers during pregnancy and their association with maternal and newborn weight status.Otilia Perichart-PereraCinthya Muñoz-ManriqueAngélica Reyes-LópezMaricruz Tolentino-DoloresSalvador Espino Y SosaMa Cristina Ramírez-GonzálezObesity during pregnancy increases the risk of adverse clinical outcomes and is associated with low-grade chronic inflammation. We describe maternal metabolic risk and inflammation by maternal weight status, and evaluate the association of metabolic and inflammatory markers with birthweight in a group of pregnant Mexican women.This study derived from a prospective cohort of healthy pregnant women <14 weeks of gestation, receiving prenatal care at National Institute of Perinatology (Mexico, 2009-2013). Metabolic and inflammatory markers were measured in maternal serum in all three pregnancy trimesters (1st: 11.42±1.7; 2nd: 21.06±2.4; 3rd: 32.74±2.3 weeks). Pregestational weight was self-reported, and body mass index (BMI) was calculated. Gestational weight gain was evaluated in the third trimester. Newborn´s weight was measured at birth. We carried out correlations, general mixed linear model and regression analyses, based on pregestational weight (self-reported), body mass index (BMI), gestational weight gain (evaluated in the third trimester) and newborn weight (measured at birth).Of the 177 women included in the study (mean age = 26.93±8.49), thirty-eight percent (n = 67) were overweight or had obesity, and 32.8% (n = 58) showed excessive gestational weight gain. We found insulin, lipids (including total cholesterol, LDL-cholesterol, HDL-cholesterol, and triglycerides-TG), leptin and interleukin 1b (IL-1b) all increased significantly (p<0.05) during pregnancy. Pregestational maternal weight status altered longitudinal concentrations of insulin, leptin, adiponectin, TG and C reactive protein. Excessive gestational weight gain was associated with higher maternal insulin in the third trimester (p<0.05). Early pregnancy leptin and TNFα were determinants of birthweight in women with normal weight, but not in overweight or obese women.Maternal weight status affected the concentrations of insulin, leptin, adiponectin, triglycerides and C reactive protein throughout pregnancy. The role of early leptin and TNFα in fetal growth need further study given the association was only observed in normal weight women. This study presents data distribution of metabolic and inflammatory markers of normal weight and overweight/obese women that did not develop GDM, preeclampsia nor macrosomia.http://europepmc.org/articles/PMC5531808?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Otilia Perichart-Perera Cinthya Muñoz-Manrique Angélica Reyes-López Maricruz Tolentino-Dolores Salvador Espino Y Sosa Ma Cristina Ramírez-González |
spellingShingle |
Otilia Perichart-Perera Cinthya Muñoz-Manrique Angélica Reyes-López Maricruz Tolentino-Dolores Salvador Espino Y Sosa Ma Cristina Ramírez-González Metabolic markers during pregnancy and their association with maternal and newborn weight status. PLoS ONE |
author_facet |
Otilia Perichart-Perera Cinthya Muñoz-Manrique Angélica Reyes-López Maricruz Tolentino-Dolores Salvador Espino Y Sosa Ma Cristina Ramírez-González |
author_sort |
Otilia Perichart-Perera |
title |
Metabolic markers during pregnancy and their association with maternal and newborn weight status. |
title_short |
Metabolic markers during pregnancy and their association with maternal and newborn weight status. |
title_full |
Metabolic markers during pregnancy and their association with maternal and newborn weight status. |
title_fullStr |
Metabolic markers during pregnancy and their association with maternal and newborn weight status. |
title_full_unstemmed |
Metabolic markers during pregnancy and their association with maternal and newborn weight status. |
title_sort |
metabolic markers during pregnancy and their association with maternal and newborn weight status. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2017-01-01 |
description |
Obesity during pregnancy increases the risk of adverse clinical outcomes and is associated with low-grade chronic inflammation. We describe maternal metabolic risk and inflammation by maternal weight status, and evaluate the association of metabolic and inflammatory markers with birthweight in a group of pregnant Mexican women.This study derived from a prospective cohort of healthy pregnant women <14 weeks of gestation, receiving prenatal care at National Institute of Perinatology (Mexico, 2009-2013). Metabolic and inflammatory markers were measured in maternal serum in all three pregnancy trimesters (1st: 11.42±1.7; 2nd: 21.06±2.4; 3rd: 32.74±2.3 weeks). Pregestational weight was self-reported, and body mass index (BMI) was calculated. Gestational weight gain was evaluated in the third trimester. Newborn´s weight was measured at birth. We carried out correlations, general mixed linear model and regression analyses, based on pregestational weight (self-reported), body mass index (BMI), gestational weight gain (evaluated in the third trimester) and newborn weight (measured at birth).Of the 177 women included in the study (mean age = 26.93±8.49), thirty-eight percent (n = 67) were overweight or had obesity, and 32.8% (n = 58) showed excessive gestational weight gain. We found insulin, lipids (including total cholesterol, LDL-cholesterol, HDL-cholesterol, and triglycerides-TG), leptin and interleukin 1b (IL-1b) all increased significantly (p<0.05) during pregnancy. Pregestational maternal weight status altered longitudinal concentrations of insulin, leptin, adiponectin, TG and C reactive protein. Excessive gestational weight gain was associated with higher maternal insulin in the third trimester (p<0.05). Early pregnancy leptin and TNFα were determinants of birthweight in women with normal weight, but not in overweight or obese women.Maternal weight status affected the concentrations of insulin, leptin, adiponectin, triglycerides and C reactive protein throughout pregnancy. The role of early leptin and TNFα in fetal growth need further study given the association was only observed in normal weight women. This study presents data distribution of metabolic and inflammatory markers of normal weight and overweight/obese women that did not develop GDM, preeclampsia nor macrosomia. |
url |
http://europepmc.org/articles/PMC5531808?pdf=render |
work_keys_str_mv |
AT otiliaperichartperera metabolicmarkersduringpregnancyandtheirassociationwithmaternalandnewbornweightstatus AT cinthyamunozmanrique metabolicmarkersduringpregnancyandtheirassociationwithmaternalandnewbornweightstatus AT angelicareyeslopez metabolicmarkersduringpregnancyandtheirassociationwithmaternalandnewbornweightstatus AT maricruztolentinodolores metabolicmarkersduringpregnancyandtheirassociationwithmaternalandnewbornweightstatus AT salvadorespinoysosa metabolicmarkersduringpregnancyandtheirassociationwithmaternalandnewbornweightstatus AT macristinaramirezgonzalez metabolicmarkersduringpregnancyandtheirassociationwithmaternalandnewbornweightstatus |
_version_ |
1725785537336311808 |